Quarterly report · Q1
9265.TEDINET S100RZJU
Period2023-06-01 → 2023-08-31
Filed2023-10-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.0bn | 2023-06-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥58.2bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.5bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥196m | 2023-06-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥259m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥213m | 2023-06-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.2bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥274m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥268m | 2023-06-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥281m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥162m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥219m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥165m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥160m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥163m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥22.6bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥23.0bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥14.6bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥16.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.0bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥7.9bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.8bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥63.53 | 2023-06-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.83 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.7 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.2% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.8% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-06-01 → 2023-08-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-06-01 → 2023-08-31 | ¥0 |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2023-08-31 | −¥268m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥73m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥73m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2023-06-01 → 2023-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥7m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥13.9bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥13.9bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2023-06-01 → 2023-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥455m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥17m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥17m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥1m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥14.0bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥14.0bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-08-31 | ¥0 |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥464m |
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2022-08-31 | −¥11m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2022-08-31 | −¥11m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2022-08-31 | −¥233m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥71m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥71m |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥0 |
| jpcrp040300-q1r_E33393-000Medical Equipment Manufacturing And Salesreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥5m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥13.4bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥13.4bn |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥11m |
| jpcrp040300-q1r_E33393-000Medical Equipment Salesreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥487m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥16m |
| jpcrp040300-q1r_E33393-000Medical Mallreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥0 |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥13.5bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥13.5bn |
| —segment total | revenue intersegment | 2022-06-01 → 2022-08-31 | ¥11m |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥493m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 350
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)荒 牧 秀 樹 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)髙 尾 圭 輔 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 13471000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 14021000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 58195000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 274000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 213000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1206000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 165000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 162000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 219000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 240000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 174000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 128000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 8036000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 7976000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 7924000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 23016000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 22586000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 24568000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 64.70 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 63.53 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 85.83 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.348 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.352 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.322 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2553000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 2553000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 2553000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 2553000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 2549200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 25492 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 3700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 2553000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 25492 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |